Latest Merck Stories
The Drug Risk Resource Center is the Web’s largest source for information on prescription drug warnings, side effects and legal news. Visit http://www.DrugRisk.com New York, NY (PRWEB) January 04, 2013 The prescription drug resource center DrugRisk.com is advising women who use the vaginal ring contraceptive NuvaRing that, amid warnings about risks of blood clots and news of injury claims filed by those affected, Merck has reported reduced sales of the devices. The goal of DrugRisk is...
ROCKLAND, Mass. and NEW YORK, Jan. 3, 2013 /PRNewswire/ -- EMD Serono, Inc., a subsidiary of Merck KGaA, Darmstadt, Germany, and Pfizer Inc. announced today that the U.S. Food and Drug Administration (FDA) approved Rebif(®) Rebidose(®) (interferon beta-1a), a single-use auto-injector for the self-administration of Rebif, a disease-modifying drug used to treat relapsing forms of multiple sclerosis (MS). (Logo: http://photos.prnewswire.com/prnh/20130103/SF36310LOGO) (Logo:...
PITTSBURGH, Jan. 2, 2013 /PRNewswire/ -- Mylan Inc. (Nasdaq: MYL) today announced that its subsidiary Mylan Pharmaceuticals has received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Applications (ANDA) for Rizatriptan Benzoate Orally Disintegrating Tablets, 5 mg (base) and 10 mg (base), and Rizatriptan Benzoate Tablets, 5 mg (base) and 10 mg (base). These products are the generic versions of Merck's Maxalt MLT® Tablets and Maxalt®...
BOCA RATON, Fla., Dec. 30, 2012 /PRNewswire/ -- Breckenridge Pharmaceutical, Inc. announced today the immediate launch of Rizatriptan Benzoate Tablets. The U.S. Food and Drug Administration granted final approval for the Abbreviated New Drug Application (ANDA) for this product, which is being manufactured and supplied by Natco Pharma Limited, and will be available in both 5mg and 10mg strengths. Rizatriptan Benzoate Tablets are AB rated to Maxalt®, a $320 million dollar brand drug...
Law firm offers no win - no fee promise for clients injured from the drug Fosamax, used to treat bone-weakening diseases. Fosamax has allegedly been linked to serious side effects, such as femur fractures, osteonecrosis of the jaw injury, esophageal cancer, and severe musculoskeletal pain. (PRWEB) December 28, 2012 Law Firm Offers No Win - No Fee Promise For Clients injured from the drug Fosamax, used to treat bone-weakening diseases. Fosamax has allegedly been linked to serious side...
WHITEHOUSE STATION, N.J., Dec. 21, 2012 /PRNewswire/ -- A gallon of gas cost 62 cents, the first Star Wars opened in movie theaters and disco ruled the dance floor. But 1977 was also a milestone year in science, technology and health care. In 1977: Apple Computer Inc. is incorporated The first MRI scan is performed on a human body The first pneumococcal polysaccharide vaccine is approved Science, technology and health care have evolved in many ways since 1977. For example, the...
CHICAGO, Dec. 20, 2012 /PRNewswire/ -- Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include AstraZeneca (NYSE:AZN), Mylan Pharma (Nasdaq:MYL), Novartis (NYSE:NVS), Teva Pharmaceuticals (NYSE:TEVA) and Merck (NYSE:MRK). (Logo: http://photos.prnewswire.com/prnh/20101027/ZIRLOGO) Get the most recent...
ROCKLAND, Mass. and NEW YORK, Dec. 20, 2012 /PRNewswire/ -- EMD Serono, Inc., a subsidiary of Merck KGaA, Darmstadt, Germany, and Fast Forward LLC, a wholly-owned subsidiary of the National Multiple Sclerosis Society, today announced the third group of recipients to receive funding through their collaboration, which is designed to accelerate innovation and commercial development of multiple sclerosis (MS) therapies. (Logo: http://photos.prnewswire.com/prnh/20121220/SF32295LOGO-a)...
GAITHERSBURG, Md., Dec. 19, 2012 /PRNewswire/ -- Sirnaomics, Inc. (www.sirnaomics.com) announced today that the company has made a major breakthrough in its novel small interfering RNA (siRNA) therapeutic product against human papillomavirus (HPV) infection and cervical cancer which was presented by Dr. Alan Lu, Executive Vice President of Sirnaomics, in the 28(th) International Papillomavirus Conference held in San Juan, Puerto Rico from Nov 30(th) to Dec 6(th), 2012. Dr. Lu's...
VANCOUVER, British Columbia, Dec. 17, 2012 /PRNewswire/ -- Pennystocksinsiders.com (PSI) has issued insider trading reports and equity research for the following companies: Research In Motion (NASDAQ:RIMM), Microsoft (NASDAQ:MSFT), Ariad (NASDAQ:ARIA), Nokia (NYSE:NOK), VeriFone (NYSE:PAY), and Williams Companies (NYSE:WMB). (Logo: http://photos.prnewswire.com/prnh/20121105/HK06856LOGO ) (Read full report by clicking the link below, you may need to copy and paste the full link to...
